chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My mom only had site soreness after her covid vaccine on 1/21 which resolved within a couple days. However, she died in the early morning hours of 1/25, she was fine the day before, no sign of injury.  We found her collapsed on the ground and although we tried cpr she was already dead.  She had gone to the hospital on 12/28 for shortness of breath, angina and symptomatic anemia, her ekg was unchanged and blood work normal except for anemia. The cardiologist did not think a cardiac cath was needed. Her shortness of breath improved with a blood transfusion and a dose of lasix (no heart failure).
For 3 days pt says she had a 3 inch red, hot, and firm area around injection site, dull headache, and low grade fever (fever for only 24 hours).
Fainted. Hit head on floor and went to ER. Likely a vasovagal syncope event observing blood in conjunction with fatigue and mild dehydration.
sick for over a week; Initial information received on 19-Oct-2020 regarding an unsolicited valid non-serious social media case received from a non-healthcare professional (consumer).  This case involves a patient of an unknown demographic who was sick for over a week (Illness), after receiving INFLUENZA VACCINE.  Medical history, medical treatments, vaccinations, concomitant medications and family history were not provided.  On an unknown date in 2002, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry date not reported) via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, (unknown latency) the patient was sick for over a week (Illness) following the administration of INFLUENZA VACCINE.   It was reported that always got it every year since it only last 90 days, I will get my second in December.  No relevant laboratory details were provided.  It was not reported if the patient received a corrective treatment.  Outcome was reported as unknown for the event Illness, at the time of reporting.  There will be no information available on the batch number for this case.
This spontaneous report was received from a Certified Medical Assistant referring to unspecified number of unspecified patients. Patients' medical history and concurrent conditions were not reported. On an unknown date, the patients were vaccinated with improperly stored ROTATEQ lot # L013193 and expiry date 20-JAN-2017, oral (strength, dose and frequency were not reported). Concomitant medications were not provided. No adverse effects were reported and no product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Russell Silver's Syndrome. Blistering and peeling raw skin over all parts of the body, pain. 03/12/07-records received from PCP. Notes of 2/280/02 document diaper rash diffuse erythemetous areas. Continues with diaper rash 03/07/02. On 03/11/02-diaper rash continues now on trunk diffuse erythemeous macular papular leions on trunk, fac and anticubital spaces. No lymphadenopathy. 5/28/03-Chicken pox.
PRESSURE ON CHEST; FORGETFUL; FEELING HEAT GOING THROUGH BODY; THROAT BEGAN TO CLOSE; DIZZINESS; TINGLING SENSATION; THROAT HURTS; FEVER; NOT FEELING WELL; This spontaneous report received from a patient concerned a 41 year old female. The patient's weight was 122 pounds, and height was 161 centimeters. The patient's concurrent conditions included penicillin allergy, abstains from alcohol, and non smoker, and other pre-existing medical conditions included no drug abuse/illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 12-MAR-2021 14:55 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced not feeling well. On 12-MAR-2021, the subject experienced tingling sensation. On 12-MAR-2021, the subject experienced throat hurts. On 12-MAR-2021, the subject experienced feeling heat going through body. On 12-MAR-2021, the subject experienced throat began to close. On 12-MAR-2021, the subject experienced dizziness. On 12-MAR-2021, the subject experienced fever. On an unspecified date, the subject experienced pressure on chest, and forgetful. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from pressure on chest, forgetful, and dizziness on 15-MAR-2021, and feeling heat going through body, throat began to close, and fever, had not recovered from tingling sensation, and throat hurts, and the outcome of not feeling well was not reported. This report was non-serious.
Received Vaccine on 4/8/2021 and had Immediate Vertigo 5 minutes after shot. I drove home scared because I was very dizzy. It is 1 month today and I still cannot drive. Left side of face went numb for a few hours on that day as well. I now have left side weakness, dizzy, off balance and lightheaded. I get occasional bouts of nausea.  Prior to getting this vaccine I was running 10 miles a day. It is now difficult to walk much less run. 1 month after getting this vaccine and I have not gone back to normal yet. I want my life back
PT DEVELOPED SWELLING AND REDNESS IN RIGHT ELBOW WHICH SPREAD TO FOREARM
I have freckles or spots on my entire body.  These spots became much darker and much more noticeable about 24 hours later.  At 36 hours after the initial dose, the spots are not noticeable again.
Patient was admitted due to confusion and poor oral intake most likely due to esophageal spasm. Pt remains hospitalized at this time
one finger and one toe bruising.; This is a spontaneous report from a contactable Nurse via medical information team. A 54-year-old female patient started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration on an unspecified date as 1st dose, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced one finger and one toe bruising after getting the Covid Vaccine. The reporter was wondering about finger and toe bruising. The reporter wanted to know about if it was a side effect of the vaccine. patient was not on any blood thinner or have bleeding disorder. The reporter stated she read it online about Covid finger; but that seems to be related to having Covid 19. The reporter asked if this was a side effect of the vaccine and it something they should be concerned about when it was time to get the second vaccine. The patient had an eye appointment to go to soon. The reporter considered the event as non-serious. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Patient received Bexsero instead of Menveo first dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 12-year-old male patient who received Men B NVS (Bexsero) (batch number KL472, expiry date 30-SEP-2024) for prophylaxis.   On 24-OCT-2023, the patient received the 1st dose of Bexsero. On 24-OCT-2023, an unknown time after receiving Bexsero, the patient experienced wrong vaccine administered (Verbatim: Patient received Bexsero instead of Menveo first dose). The outcome of the wrong vaccine administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date- 25-OCT-2023 The medical assistant reported that a patient received Bexsero instead of Menveo 1st dose, which led to wrong vaccine administered. The reporter consented to follow up.
This is a spontaneous report from a contactable Other HCP via Pfizer sales representative. A male patient at age 18 or 19 received TRUMENBA, via an unspecified route of administration at single dose on an unspecified date for immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced reversible cerebral vasoconstriction syndrome and headache with outcome of unknown. The patient underwent lab tests and procedures included on an unspecified date spinal tap and an MRI which led to the diagnosis of reversible cerebral vasoconstriction syndrome. The information on the lot number has been requested. Amendment: This follow-up report is being submitted to amend previously reported information: Case comment updated. Sender's Comments: The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, as appropriate. The case will be reassessed if additional information becomes available.
mom could not recall course of events due to length of time from event; from records of MD-reported sz PM of 28MAY93 w/fever of 100.8; phenobarbital was inc to 5 ml;
This spontaneous report as received from a pharmacist refers to a patient of unknown age. On 16-FEB-2013 the patient was vaccinated with a dose of GARDASIL (lot # 667165/1167Z, expired date 08-DEC-2012). No adverse effect reported. It was unknown if the patient had sought medical attention. The outcome of the patient was unknown. Additional information has been requested.
VACCINE BREAKTHROUGH COVID INFECTION - Symptoms lasted for several days, required consultation with physicians and extra care at home, but did not necessitate in-person medical care. (Prior to receiving vaccine, patient was high risk for severe disease due to neurological disease and history of complications with colds) 9/29/2022 (Day of positive test): Congestion, fatigue 9/29 - 10/2/2022: Vomiting increased from baseline, a bit dehydrated, a 100.2 fever, elevated heart rate (at one point it was 170s/180s but got better in time for us to avoid the ER), upper and lower congestion, slightly more labored than usual breathing, and coughing a fair amount, especially at night. Parents kept in touch with pt.'s pulmonologist for recommendations, and so he was able to be cared for at home. He was mostly recovered by 10/2/22. At-home care slightly more than typically needed for colds (history of emergent care needed during colds for respiratory issues, dehydration, etc). At-home care included: monitoring of oxygen and heart rate via medical-grade Covidien pulse oximeter, increased chest physiotherapy, medical-grade nasal suction, substitute pedialyte for 1/2 of g-tube feeds, acetaminophen/ibuprofen, saline nasal spray, saline mist inhaler, mucinex at night, albuterol inhaler every 4 hours.
Blood clot in right wrist area:   On the evening of 3/17/21, I felt sudden pain in the palm of my right hand, just above the wrist. Then the vein just below my wrist swelled up and turned blue. The next morning when I woke, the vein was no longer swollen, but the area below my wrist had a large bruise, which lasted several days.   I contacted my physician that day (3/18) who said just to monitor/observe and come in if continuing issues (which there were not).
Vaccine leaked from the injection site. The dose was repeated intradermally and was successful. No adverse even occurd.
Received call 8/7/08, child in severe left shoulder pain.  Patient seen - injection site not warm/tender/erythemateous.  Patient complained of severe left shoulder pain - strength WNL, ROM WNL.  Given Vicodan/ice.  8/13/08 received call from dad, pain now > right arm and decreased mobility of left = ortho consult suggested ASAP.  8/13/08 received call from ER.  8/14/08 again sugg ortho, our office made appt for 8/15/08.
Information has been received from an office manager concerning a patient who was vaccinated with a dose of VARIVAX (Merck) (lot # 663530/0052Y) instead of ZOSTAVAX (Merck).  This event was a result of human error, not product confusion.  No adverse effects were reported.  At the report time the outcome was unknown.  Additional information has been requested.
Right arm 5x6 cm erythema and 1.5 cm induration; #5 DTAP, #2 MMR on right arm. Treated with warm compress and Rocephin and PO Augmentin.
Mild swelling/redness around injection site. Dtap allergic reaction in appearance. Red, nontender, itchy, indurated at 2" from site.
Headache, Myalgia, Pain/Discomfort, redness, and soreness at injection site, fatigue, body aches Narrative:
7.5 by 7.5 cm local reaction to DTaP on right thigh.
pt reported that the next day after receiving her IMZ she had a red rashy area at site of injection, it was swollen , and sore.  She was upset that we did  both injections in the same arm, but she indicated that she is not able to get injections in her right arm due to previous chemo in that arm.  We assured her  that it is ok per protocol to administer 2 in one arm, as long as they are 1 inch apart, and that the reaction she was having was very typical of side effects of the Pneumovax 23 in particular.  Pt took some ibuprofen and put a heating pad on it, and was going to have the doctor look at it, as she was going to the office for something else anyway.
No adverse event that we are yet aware of. Patient was inadvertently given 1 dose of Pfizer 4 weeks after having received 1 dose of Moderna Covid-19 vaccinations.
had first vaccine, contacted Covid; This case was reported by a consumer via call center representative and described the occurrence of covid-19 in a 74-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th May 2022, the patient received the 1st dose of Shingrix. On 15th June 2022, 31 days after receiving Shingrix, the patient experienced covid-19. On an unknown date, the outcome of the covid-19 was recovering/resolving.   It was unknown if the reporter considered the covid-19 to be related to Shingrix.     Additional Information: GSK Receipt Date: 22-JUL-2022 Reporter's Comments: The case was reported via interactive digital media. The patient received his first Shingrix vaccine on 15th May of this year. The patient was contacted Covid on 15th June and tested negative on 27th June. The patient asked when he could have 2nd Shingrix shot after recovering from Covid.
Tingling, numbness starting in right upper lip, spreading up to orbital area/temple - stroke-like symptoms
Died 2 days after receiving routine 4 month vaccines. Reportedly, developed upper respiratory congestion, limpness, was taken to the ED, went into respiratory arrest and died. The mom states the death was linked to "pneumococcal vaccine in her lungs and blood".
Collapsed after 10 minutes of receiving Tdap and MENVEO. Px hit back of head on wall. Per mom, Px appeared to have a seizure.
Moderna  covid vaccine EUA   Fatigue, lethargy, headache, dizziness, nausea, diarrhea, abdominal pain, chills, sweats, muscles aches, injection site pain and swelling, visual disturbance    Still having all symptoms with improvement
Sudden onset of dizziness that has lasted 12 hours so far. Itchiness that woke me in the night and itching of head and face in the morning of 11/24.
That night I started aching up left arm and into neck next am. Then each day following it felt like spasms in back, shoulder working all down my back for nearly 1 week. The neck stayed for 2 weeks. Got headaches towards end. Bed rest.
24 hrs later, Severe headache, dizziness, muscle and joint pain in neck, hips and legs. Loss of appetite. intermittent fast heart rate. I took 3 ibuprofen at 11:30 am with no relief. I napped for two hours 12:30-2:30 with no relief. I took 2 acetaminophen at 3:00 with no relief. I could not function normally.  I took 4 ibuprofen at 6pm with some relief.  The next day 48 hrs later I still felt a mild headache and mild muscle and body aches.  I was able to function.  mild popup headaches on day 3 & 4. Better with 3 ibuprofen.
Case number PHEH2012US021634 is an initial spontaneous report received from an office manager on 24 Oct 2012 with the follow-up received on 27 Nov 2012 and a follow up report from the health care professional received on 15 Apr 2013 with a follow up report received from the physician on 04 Apr 2014: This report refers to a 35 year old female pregnant patient. Her vaccination history included vaccination with an unspecified vaccine and tolerated it. Her concomitant medication included VITAFUSION and Prenatal. Her last menstrual period was reported as 22 May 2012 with expected date of delivery as 02 Mar 2013. She was 22 weeks pregnant when she got vaccinated with an expired FLUVIRIN (batch number: 11161P) at dose of 0.5 ml intramuscularly on 24 Oct 2012 at 15:30 PM. No adverse event was reported following this administration error. She underwent prenatal tests on 19 Jul 2012, 02 Oct 2012, 31 Jan 2013 and 01 Feb 2013 (biophysical profile) and all the results were normal. She had caesarean section on 18 Feb 2013 (nuchal cord x2). She gave birth to a normal healthy male child with 7 lbs/oz weight. The APGAR score was reported as 7 at 1 min and 9 at 5 mins. No malformations were observed in the new born child. The case was reported as a non serious case by the health care professional. No other information was available. Follow-up received on 27 Nov 2012: Updated patient weight and weight, concomitant medication, vaccine dose and time. Follow up report from the health care professional received on 15 Apr 2013: The lab tests, medical history of the patient, last menstrual period, expected date of delivery, delivery details, information related to the new born and seriousness were updated. Follow up report was received from the physician on 04 Apr 2014: The patient's height and the current status of the baby were updated.
PT BEGAN TO FEEL LIGHTHEADED AND THEN PASSED OUT. LOC FOR 5-10 SECONDS. DROP IN BLOOD PRESSURE/PULSE 88/55 & 57 RESPECTIVELY.  PT REMAINED HYPOTENSIVE AND LETHARGIC >5 MINUTES SO EPINEPHRINE 0.3MG WAS ADMINISTERED IM.  PT REMAINED IN THE OFFICE UNDER CONTINUAL VITALS MONITORING FOR >35 MINUTES UNTIL HIS BP & PULSE RETURNED TO NORMAL AND HE WAS NO LONGER SYMPTOMATIC.
pt recvd vax 20OCT93 & exp febrile seizure; seen in ER & admitted for observation of transient lt sided focal weakness; CT Scan nl;
Flesh colored rash all over her body; itchy; Looks like patches of ruptured blood vessels; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Flesh colored rash all over her body), PRURITUS (itchy) and PETECHIAE (Looks like patches of ruptured blood vessels) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     The patient's past medical history included No adverse event (no reported medical history). Concomitant products included VALSARTAN, HCTZ, LEVOTHYROXINE, CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE (VITAMIN B 1-6-12), MAGNESIUM, CALCIUM, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and FISH OIL for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced RASH (Flesh colored rash all over her body), PRURITUS (itchy) and PETECHIAE (Looks like patches of ruptured blood vessels). At the time of the report, RASH (Flesh colored rash all over her body), PRURITUS (itchy) and PETECHIAE (Looks like patches of ruptured blood vessels) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Chest pressure similar to being in a swimming pool, shortness of breath, entire body shaking, Charlie Horse cramps in calves and feet arches, big toe twitching
Information has been received from an investigator concerning a 14 month old male who entered a study. On 18-AUG-2007 the patient was vaccinated with VAQTA inactivated. The patient received MMR II and PREVNAR on 07-JUL-2007. On 24-AUG-2007 the patient began experiencing diarrhea. The patient was subsequently hospitalized. Treatment medications included PEDIALYTE 20 oz, IV D5 1/4NS (40 cc/hr), IMODIUM 5 ml. All medication were for diarrhea. ON 29-AUG-2007 a stool analysis was performed with normal results. The patient recovered from diarrhea. Follow-up information was received on 18-APR-2008. The SAE was changed to gastroenteritis with dehydration. The patient was also treated with acetaminophen on 30-AUG-2007. The patient's medical history was significant for frequent ear infections. He had no known drug allergies. On 30-AUG-2007 the patient was seen in the emergency room and had been experiencing bouts of diarrhea every day since 27-AUG-2007. The diarrhea was loose and watery with green discoloration. There was no mucous or blood and he had no associated vomiting or fever. Vital signs were: temperature 99.1 F, pulse 124, respirations 24 and pulse oximetry 98%. Oropharyngeal examination showed mild congestion and his lips appeared dry. Labs were: WBC 16.8, neutrophil 14%, no bands, glucose 95, BUN 7, creatinine 0.3, sodium 138, potassium 4.1, chloride 104. Urine was clear and negative for microscopic exam. Blood culture collected on 30-AUG-2007 showed no growth at 5 days. The patient was subsequently admitted to the hospital. The patient recovered from gastroenteritis with dehydration. The investigator considered the gastroenteritis with dehydration to be related to study medication.
TEMPORAL ARTERITIS; CHILLS; SWOLLEN LYMPH NODES; This spontaneous report received from a patient concerned a 78 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022 expiry: UNKNOWN) dose was not reported, administered on 13-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 2021, the subject experienced swollen lymph nodes. On 13-MAR-2021, the subject experienced temporal arteritis. On 13-MAR-2021, the subject experienced chills. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from temporal arteritis, swollen lymph nodes, and chills on 2021. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as case assessed as non-serious
Patient came in for a COVID Vaccine Booster shot. Post administration it was noted that the patient received a COVID Vaccine Booster on 10/12/22 (i.e. 4 weeks earlier). Was too soon.
patient became syncopal/unresponsive for about 3-4 minutes, EMS called, wife performed chest compressions. He was evaluated by EMS but not transported. He felt "foggy" and tired the remainder of the day but back to normal the next day.
Patient developed a raspy voice the day after her vaccination. It has persisted through today. She tested positive for COVID-19 on 2/9/2022.